Skip to content
  • Lab Home
  • Research
  • People
    • Lab Members
    • Alumni
  • Publications
  • News
  • Contact
Donate to ISB
clear

News

Postdoc Journey Video

Posted: February 10, 2026

Philanthropy Baliga Lab Fellows
Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus

Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus

Postdoctoral fellows are the lifeblood of research institutions, yet their contributions are often underrecognized. At the Institute for Systems Biology (ISB), postdocs enter the scientific workforce with passion, vision, and advanced training – bringing the fresh ideas that fuel discovery.

Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus
Behind the Breakthroughs: ISB’s Postdoctoral Fellows in Focus
Diagram showing a cycle of precision health data. On the left, a user is surrounded by a "Dense, Dynamic Data Cloud" including Wearables, Omics, Exposome, and EHRs. Arrows point to "Longitudinal Data" tracking personal baselines over a lifespan. This feeds into "AI Models" for pattern detection, which outputs "Actionable Possibilities" for personalized recommendations, pointing back to the user.

Posted: January 26, 2026

Chronic Illness Press Release Advancing Health
AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive

AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive

Researchers at the Institute for Systems Biology argue that combining systems biology, longitudinal multiomics data, and artificial intelligence could transform healthcare from reactive treatment to proactive prevention, enabling scientists and clinicians to detect early molecular signs of disease and intervene before symptoms appear.

AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive
AI-Era Early Detection Is Shifting Healthcare from Reactive to Proactive

More News (Heath Lab)

 
screenshot of video for Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

Posted: January 25, 2022

Infectious Disease Press Release COVID and Long COVID
Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.

Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis
Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis
Drs. Jim Heath, Yapeng Su and Jihoon Lee

Posted: September 6, 2021

Infectious Disease Press Release COVID and Long COVID
Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival

Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival

Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations have uncovered underlying metabolic changes that regulate how immune cells react to COVID-19. These findings are associated with COVID-19 severity and may predict patient survival. The work was published in the journal Nature Biotechnology.

Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival
Metabolic Changes in Plasma and Immune Cells Associated with COVID-19 Severity, May Predict Patient Survival
View All News
  • Research
    • Research
  • People
    • People
    • Alumni
  • Publications
    • Publications
  • News
    • News
  • Contact
    • Contact
ISB logo (1-color)
Donate to ISB Contact ISB

Subscribe to Molecular Me, where we share news of our transformational research, devoted scientists and educators, upcoming events, and more.

© 2026 Hood Lab. All Rights Reserved
  • Login
  • Intranet